NCT03775044View on ClinicalTrials.gov

Assessment of Medherent Medication Management Device and Adherence Platform

NAActive, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2023

Conditions
Mental Health DisorderMedication Adherence
Interventions
DEVICE

Medherent Device

The Medherent Medication Management Device (MMD) is intended to enable patients to self-manage their medication at home when it may otherwise require assistance.

Trial Locations (1)

21401

Terrapin Pharmacy, Annapolis

All Listed Sponsors
collaborator

University of Maryland

OTHER

lead

Terrapin Pharmacy

INDUSTRY